EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of HIV-related non-Hodgkins lymphoma adapted to prognostic factors



Treatment of HIV-related non-Hodgkins lymphoma adapted to prognostic factors



JAIDS Journal of Acquired Immune Deficiency Syndromes 21(1): A32, May 1




(PDF 0-2 workdays service: $29.90)

Accession: 035980464

Download citation: RISBibTeXText



Related references

Prognostic factors and treatment outcome in primary progressive Hodgkins lymphoma A report from the German Hodgkins Lymphoma Study Group. Blood 94(10 SUPPL 1 PART 1): 514a, Nov 15, 1999

Age and LDH are independent prognostic factors also in HIV-related non-Hodgkins lymphoma A monoinstitutional study of 96 patients. European Journal of Cancer 32A(SUPPL 1): S38, 1996

Intensive chemotherapy for HIV-related non-Hodgkins lymphoma Long-term follow-up and prognostic factors. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Eleventh International Conference on AIDS, Vol Two One world: One hope : 290, 1996

AIDS-related non-Hodgkins lymphoma Response to chop chemotherapy and prognostic factors in 46 patients. British Journal of Haematology 102(1): 239, July 1, 1998

Non hodgkins lymphoma nhl of the thyroid gland prognostic factors and treatment outcome. Clinical & Investigative Medicine 15(4 SUPPL): A137, 1992

The influence of prognostic factors on survival in hodgkins disease and non hodgkins lymphoma. Bulletin of the Alexandria Faculty of Medicine 16(2): 225-238, 1980

Therapy of HIV-related non-Hodgkins lymphoma An European multicentric randomized study in patients stratified according to their prognostic factors Preliminary results. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 14(4): A53, 1997

The results of treatment in patients with non-Hodgkins lymphoma The analysis of prognostic factors and evaluation of the role of radiotherapy. European Journal of Cancer 37(Supplement 6): S93, October, 2001

FDG-PET for post-treatment evaluation in Hodgkins disease and non-Hodgkins lymphoma has higher diagnostic and prognostic value than CT imaging. Journal of Nuclear Medicine 39(5 SUPPL ): 254P, 1998

Analysis of standard-chop dose intensity, its treatment schedule, and prognostic factors for diffuse large non-Hodgkins lymphoma. Blood 92(10 SUPPL 1 PART 1-2): 232B, Nov 15, 1998

The International Prognostic Index is the most useful prognostic indicator in HIV-related non-Hodgkins lymphoma. Blood 90(10 SUPPL 1 PART 2): 268B, Nov 15, 1997

Whole-body FDG-PET post-treatment evaluation in Hodgkins disease and non-Hodgkins lymphoma has higher diagnostic and prognostic value than classical CT scan imaging. Blood. 90(10 Suppl. 1 Part 1): 336a,. 15, 1997

Whole-body FDG-PET for post treatment evaluation in Hodgkins disease and non-Hodgkins lymphoma has higher diagnostic and prognostic value than classical CT scan imaging. European Journal of Cancer 34(SUPPL 2): S25, 1998

T-cell non-Hodgkins lymphoma Clinical presentation, histology, treatment outcome and prognostic factors of 66 patients treated at a single institution. Blood 96(11 Part 2): 245b, November 16, 2000

Follicular small cleaved cell non-Hodgkins lymphoma Results of treatment and prognostic factors for 165 patients treated at a single institution. Blood 82(10 SUPPL 1): 136A, 1993